(iii) The ACO fails to earn sufficient shared savings in a performance year to repay the prepaid shared savings they received during that performance year
Solicitation of Public Comments The Innovation Center is releasing this request for information (RFI) to gather feedback on testing a new model design to improve clinical outcomes and reduce or maintain Medicare spending
Beginning in CY 2006 (1) A supplying fee of $24 is paid to a pharmacy (no more often than once every 30 days) for the first prescription of drugs and biologicals described in sections 1861(s)(2)(J), 1861(s)(2)(Q), and 1861(s)(2)(T) of the Act, that the pharmacy provided to a beneficiary, except as provided in paragraph (a)(2) of this section
To evaluate whether a generic drug approved under an ANDA meets all the criteria in section 1860D-14B(g)(1)(C)(ii) of the Act, CMS proposes in 428.101(a)(3) to codify the policy established in section 30 of the revised Medicare Part D Drug Inflation Rebate Guidance whereby CMS would use specified FDA resources such as the Approved Drug Products with Therapeutic Equivalence Evaluations (commonly known as the Orange Book) [581] and NDC Directory to determine whether a generic drug meets the definition of a Part D rebatable drug
In Indonesia, kretek smokers face a 13 to 20 times greater risk of abnormal lung function and a higher risk of acute lung injury, particularly among those with respiratory issues
